Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.81 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.70 |
| ▸ | RARA | P10276 | 6/20 | 0.70 |
| ▸ | RXRA | P19793 | 5/20 | 0.70 |
| ▸ | RARB | P10826 | 4/20 | 0.70 |
| ▸ | RARG | P13631 | 4/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.70 |
| ▸ | RXRB | P28702 | 2/20 | 0.70 |
| ▸ | RXRG | P48443 | 2/20 | 0.70 |
| ▸ | RORC | P51449 | 2/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.70 |
| ▸ | HTR2B | P41595 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.70 |
| ▸ | DRD3 | P35462 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1578435 | 1.00 | MAPT (0.81) | MAPTALOX15ALDH1A1RARARXRA | |
| SCHEMBL3708856 | 1.00 | MAPT (0.81) | MAPTALOX15ALDH1A1RARARXRA | |
| SCHEMBL9007198 | 1.00 | MAPT (0.81) | MAPTALOX15ALDH1A1RARARXRA | |
| SCHEMBL3334775 | 1.00 | MAPT (0.81) | MAPTALOX15ALDH1A1RARARXRA | |
| SCHEMBL1578472 | 1.00 | MAPT (0.81) | MAPTALOX15ALDH1A1RARARXRA | |
| SCHEMBL161114 | 1.00 | MAPT (0.81) | MAPTALOX15ALDH1A1RARARXRA | |
| SCHEMBL3502557 | 1.00 | MAPT (0.81) | MAPTALOX15ALDH1A1RARARXRA | |
| SCHEMBL12494856 | 0.92 | MAPT (0.68) | MAPTALOX15ALDH1A1RARARXRA | |
| SCHEMBL17099746 | 0.92 | MAPT (0.68) | MAPTALOX15ALDH1A1RARARXRA | |
| SCHEMBL25378972 | 0.90 | MAPT (0.81) | MAPTALOX15ALDH1A1RARARXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 409 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260009005-A1 | GENERATING DORSAL FOREGUT, AND ANTERIOR DOMAIN, ENDODERM CELLS | THE CLEVELAND CLINIC FOUNDATION | 2026-01-08 | — | — | US | claimed |
| US-12435315-B2 | Generating dorsal foregut, and anterior domain, endoderm cells | THE CLEVELAND CLINIC FOUNDATION (US) | 2025-10-07 | — | — | US | claimed |
| US-20250304916-A1 | METHODS AND COMPOSITIONS FOR GENERATING VASCULAR LEPTOMENINGEAL CELLS | TRAILHEAD BIOSYSTEMS INC (US) | 2025-10-02 | — | — | US | claimed |
| EP-4577639-A1 | METHODS AND COMPOSITIONS FOR SMALL MOLECULE BASED PANCREATIC BETA CELL INDUCTION | Trailhead Biosystems Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| EP-4577641-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEMOGENIC ENDOTHELIAL CELLS FROM PLURIPOTENT STEM CELLS | Trailhead Biosystems Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| EP-4569090-A2 | METHODS AND COMPOSITIONS FOR GENERATING OLIGODENDROCYTE PROGENITOR CELLS | Trailhead Biosystems Inc. (US) | 2025-06-18 | — | — | EP | claimed |
| EP-3967299-B1 | PKC ACTIVATORS AND COMBINATIONS THEREOF FOR TREATING ALZHEIMER DISEASE | COGNITIVE RES ENTERPRISES INC (US) | 2025-06-18 | — | — | EP | claimed |
| EP-4558612-A1 | METHODS AND COMPOSITIONS FOR GENERATING ENDOTHELIAL CELLS FROM PLURIPOTENT STEM CELLS | Trailhead Biosystems Inc. (US) | 2025-05-28 | — | — | EP | claimed |
| CN-119768510-A | Methods and compositions for producing hematopoietic endothelial cells from pluripotent stem cells | 特雷尔赫德生物系统股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119654404-A | Methods and compositions for producing oligodendrocyte progenitor cells | 特雷尔赫德生物系统股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| US-20010049365-A1 | Vitamin D analog and a retinoid, wherein: the retinoid is 4-oxo-retinol, 4-oxo- retinal, or 4-oxo-retinyl ester; also restoring the natural color of gray hair; treating hair and skin disorders | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) | 2001-12-06 | — | — | US | claimed |
| EP-1104294-A1 | COMPOSITIONS AND METHODS OF TREATING ABNORMAL CELL PROLIFERATION | Achkar, Charles C. (US) | 2001-06-06 | — | — | EP | claimed |
| WO-2000003700-A1 | COMPOSITIONS AND METHODS OF TREATING ABNORMAL CELL PROLIFERATION | ACHKAR CHARLES C (US) | 2000-01-27 | — | — | WO | claimed |
| EP-0071598-B1 | THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FURBEARING ANIMALS | BAZZANO, Gail S (US) | 1990-05-09 | — | — | EP | claimed |
| EP-0093770-A4 | THE USE OF RETINOIDS AND MINOXIDIL (2,4-DIAMINO-6-PIPERIDINO-PYRIMIDINE-3-OXIDE) TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO TREAT CERTAIN TYPES OF ALOPECIAS. | BAZZANO GAIL S | 1987-11-25 | — | — | EP | claimed |
| EP-0093770-A1 | THE USE OF RETINOIDS AND MINOXIDIL (2,4-DIAMINO-6-PIPERIDINO-PYRIMIDINE-3-OXIDE) TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO TREAT CERTAIN TYPES OF ALOPECIAS. | BAZZANO GAIL S | 1983-11-16 | — | — | EP | claimed |
| WO-1983002558-A1 | THE USE OF RETINOIDS AND MINOXIDIL (2,4,-DIAMINO-6-PIPERIDINO-PYRIMIDINE-3-OXIDE) TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO TREAT CERTAIN TYPES OF ALOPECIAS | BAZZANO, GAIL, SANSONE | 1983-08-04 | — | — | WO | claimed |
| EP-0071598-A4 | THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FURBEARING ANIMALS. | BAZZANO GAIL S | 1983-06-08 | — | — | EP | claimed |
| EP-0071598-A1 | THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FURBEARING ANIMALS. | BAZZANO GAIL S | 1983-02-16 | — | — | EP | claimed |
| WO-1982002833-A1 | THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FUR-BEARING ANIMALS | BAZZANO GAIL SANSONE | 1982-09-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010049365-A1 | Vitamin D analog and a retinoid, wherein: the retinoid is 4-oxo-retinol, 4-oxo- retinal, or 4-oxo-retinyl ester; also restoring the natural color of gray hair; treating hair and skin disorders | RBP4, VDR, CYP24A1 | MAPT 4178/4885ALOX15 970/4885ALDH1A1 234/4885 |
| US-20260009005-A1 | GENERATING DORSAL FOREGUT, AND ANTERIOR DOMAIN, ENDODERM CELLS | BMP4, BMPR2, DACH1 | MAPT 2991/4885ALOX15 3303/4885ALDH1A1 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.